Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yeo, Adeline S L ^a   Azhar, Nur Atiqah ^a,b   Yeow, Wanyi ^b   Talbot Jr , C Conover ^c   Khan, Mohammad Asif ^b,c   Shankar, Esaki M ^a   Rathakrishnan, Anusyah ^a   Azizan, Azliyati ^d   Wang, Seok Mui ^e   Lee, Siew Kim ^a   Fong, Mun Yik ^a   Manikam, Rishya ^f   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b PERDANA UNIVERSITY   (Malaysia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^f UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; B7 ANTIGEN; CD28 ANTIGEN; COMPLEMENT COMPONENT C1S; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; NEUTRALIZING ANTIBODY; NEUTROPHIL COLLAGENASE; RANTES; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MATRIX METALLOPROTEINASE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; ASYMPTOMATIC INFECTION; C1S GENE; CCL3L1 GENE; CCL4L1 GENE; CCL5 GENE; CD28 GENE; CD80 GENE; CFB GENE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENGUE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IL10 GENE; IL13 GENE; IL18 GENE; IL2 GENE; IL3 GENE; IL4 GENE; IL5 GENE; IL8 GENE; IL9 GENE; INNATE IMMUNITY; MMP10 GENE; MMP12 GENE; MMP15 GENE; MMP16 GENE; MMP24 GENE; MMP8 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; SWINE; TGFB GENE; TIMP1 GENE; TNF GENE; UPREGULATION; DENGUE VIRUS; FEMALE; MALE; METABOLISM; PATHOGENICITY; SIGNAL TRANSDUCTION; VIROLOGY;

ANTIBODIES, NEUTRALIZING; CYTOKINES; DENGUE; DENGUE VIRUS; DOWN-REGULATION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899647893     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092240     Document Type: Article

References (82)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature.
2. Gubler DJ, Rosen L (1976) Variation among geographic strains of Aedes albopictus in susceptibility to infection with dengue viruses. The American journal of tropical medicine and hygiene 25: 318.
3. Platt KB, Linthicum KJ, Myint K, Innis BL, Lerdthusnee K, et al. (1997) Impact of dengue virus infection on feeding behavior of Aedes aegypti. The American journal of tropical medicine and hygiene 57: 119-125.
4. Putnam JL, Scott TW (1995) Blood-feeding behavior of dengue-2 virus-infected Aedes aegypti. The American journal of tropical medicine and hygiene 52: 225-227.
5. Dengue W (2009) Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization.
6. Siler JF, Hall MW, Hitchens AP (1925) REsults obtained in the transmission of dengue fever. Journal of the American Medical Association 84: 1163-1172.
7. Endy TP, Anderson KB, Nisalak A, Yoon I-K, Green S, et al. (2011) Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS neglected tropical diseases 5: e975.
8. Mathew A, Rothman AL (2008) Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunological reviews 225: 300-313.
9. Gubler DJ, Reed D, Rosen L, Hitchcock Jr J (1978) Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. The American journal of tropical medicine and hygiene 27: 581-589.
10. Bravo J, Guzman M, Kouri G (1987) Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Transactions of the Royal Society of Tropical Medicine and Hygiene 81: 816-820.
11. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. Journal of Infectious Diseases 179: 755-762.
12. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. Journal of Infectious Diseases 181: 2-9.
13. Morens DM, Halstead S (1990) Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. Journal of general virology 71: 2909-2914.
14. Lei H-Y, Yeh T-M, Liu H-S, Lin Y-S, Chen S-H, et al. (2001) Immunopathogenesis of dengue virus infection. Journal of biomedical science 8: 377-388.
15. Diamond MS (2003) Evasion of innate and adaptive immunity by flaviviruses. Immunology and cell biology 81: 196-206.
16. Navarro-Sánchez E, Desprès P, Cedillo-Barrón L (2005) Innate immune responses to dengue virus. Archives of medical research 36: 425-435.
17. Shresta S (2012) Role of complement in dengue virus infection: protection or pathogenesis? mBio 3.
18. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, et al. (2012) Into the eye of the cytokine storm. Microbiology and Molecular Biology Reviews 76: 16-32.
19. Fink J, Gu F, Vasudevan SG (2006) Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Reviews in medical virology 16: 263-275.
20. Luplertlop N, Luplerdlop N, Missé D, Bray D, Deleuze V, et al. (2006) Denguevirus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO reports 7: 1176-1181.
21. Chaturvedi U, Agarwal R, Elbishbishi E, Mustafa A (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunology & Medical Microbiology 28: 183-188.
22. Kurane I, Ennis FA. Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever; 1994. Elsevier. pp. 443-448.
23. Harris R, Ukaejiofo E (1969) Rapid preparation of lymphocytes for tissue-typing. The Lancet 294: 327.
24. Lam S, Devi S, Pang T (1987) Detection of specific IgM in dengue infection. Southeast Asian journal of tropical medicine and public health 18: 532-538.
25. Clarke DH, Casals J (1958) Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. The American Journal of Tropical Medicine and Hygiene 7: 561-573.
26. Kong YY, Thay CH, Tin TC, Devi S (2006) Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR. Journal of virological methods 138: 123-130.
27. Russell PK, Nisalak A, Sukhavachana P, Vivona S (1967) A plaque reduction test for dengue virus neutralizing antibodies. The Journal of Immunology 99: 285-290.
28. Vanja L, Laurie HG (2011) T-bet in disease. Nature Immunology 12: 597-606.
29. Thomas SJ, Hombach J, Barrett A (2009) Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development. Vaccine 27: 355-368.
30. Kyle JL, Balsitis SJ, Zhang L, Beatty PR, Harris E (2008) Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 380: 296-303.
31. Garc?́a G, Sierra B, Pérez AB, Aguirre E, Rosado I, et al. (2010) Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FccRIIa polymorphism. The American journal of tropical medicine and hygiene 82: 1153.
32. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454: 428-435.
33. Nasirudeen A, Wong HH, Thien P, Xu S, Lam K-P, et al. (2011) RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS neglected tropical diseases 5: e926.
34. Matsumoto M, Seya T (2008) TLR3: interferon induction by double-stranded RNA including poly (I: C). Advanced drug delivery reviews 60: 805-812.
35. Liang Z, Wu S, Li Y, He L,Wu M, et al. (2011) Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-b in cultured hepatoma cells. PloS one 6.
36. Tsai Y-T, Chang S-Y, Lee C-N, Kao C-L (2009) Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cellular microbiology 11: 604-615.
37. Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, et al. (2008) Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. Journal of Infectious Diseases 197: 1459-1467.
38. Gomes ALV, Wee LJ, Khan AM, Gil LH, Marques Jr. ET, et al. (2010) Classification of dengue fever patients based on gene expression data using support vector machines. PloS one 5: e11267.
39. Guzman MG, Vazquez S (2010) The complexity of antibody-dependent enhancement of dengue virus infection. Viruses 2: 2649-2662.
40. Van Sorge N, Van Der Pol WL, Van de Winkel J (2003) FccR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue antigens 61: 189-202.
41. Zola H (2007) Leukocyte and stromal cell molecules: The CD markers: Wiley. com.
42. Rogers KA, Scinicariello F, Attanasio R (2006) IgG Fc receptor III homologues in nonhuman primate species: genetic characterization and ligand interactions. The Journal of Immunology 177: 3848-3856.
43. Malasit P (1987) Complement and dengue haemorrhagic fever/shock syndrome. The Southeast Asian journal of tropical medicine and public health 18: 316-320.
44. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, et al. (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. The Journal of infectious diseases 193: 1078-1088.
45. Cardosa M, Porterfield J, Gordon S (1983) Complement receptor mediates enhanced flavivirus replication in macrophages. The Journal of experimental medicine 158: 258-263.
46. Avirutnan P, Fuchs A, Hauhart R, Somnuke P, Youn S, et al. (2010) Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. The Journal of experimental medicine 207: 793-806.
47. Libraty D, Pichyangkul S, Ajariyakhajorn C, Endy T, Ennis F (2001) Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. Journal of virology 75: 3501-3508.
48. Lechmann M, Berchtold S, Steinkasserer A, Hauber J (2002) CD83 on dendritic cells: more than just a marker for maturation. Trends in immunology 23: 273-275.
49. Mathew A, Kurane I, Green S, Vaughn D, Kalayanarooj S, et al. (1999) Impaired T cell proliferation in acute dengue infection. Journal of immunology (Baltimore, Md : 1950) 162: 5609-5615.
50. Ramapraba A, Tan Lian H, Lucy Lum Chai S, Phoay Lay T, Jamuna V, et al. (2007) Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin Vaccine Immunol 14: 969-977.
51. Zhu J, Paul WE (2010) Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunological reviews 238: 247-262.
52. Lazarevic V, Glimcher LH (2011) T-bet in disease. Nature immunology 12: 597-606.
53. Chaturvedi U, Raghupathy R, Pacsa A, Elbishbishi E, Agarwal R, et al. (1999) Shift from a Th1-type response to Th2-type in dengue haemorrhagic fever. Current science 76: 63-69.
54. Agarwal R, Elbishbishi E, Chaturvedi U, Nagar R, Mustafa A (1999) Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever. International journal of experimental pathology 80: 143-150.
55. Jain A, Pandey N, Garg R, Kumar R (2013) IL-17 level in patients with Dengue virus infection & its association with severity of illness. Journal of clinical immunology 33: 613-618.
56. Raghupathy R, Chaturvedi U, Al-Sayer H, Elbishbishi E, Agarwal R, et al. (1998) Elevated levels of IL-8 in dengue hemorrhagic fever. Journal of medical virology 56: 280-285.
57. Mustafa A, Elbishbishi E, Agarwal R, Chaturvedi U (2001) Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS immunology and medical microbiology 30: 229-233.
58. Appanna R, Wang SM, Ponnampalavanar SA, Lum LCS, Devi Sekaran S (2012) Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells. American Journal of Tropical Medicine and Hygiene 87: 936.
59. Mathew A, Rothman A (2008) Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunological reviews 225: 300-313.
60. Rothman A (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nature reviews Immunology 11: 532-543.
61. Chaturvedi U, Agarwal R, Elbishbishi E, Mustafa A (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS immunology and medical microbiology 28: 183-188.
62. Chaturvedi U, Elbishbishi E, Agarwal R, Raghupathy R, Nagar R, et al. (1999) Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. Journal of medical virology 59: 335-340.
63. Hober D, Poli L, Roblin B, Gestas P, Chungue E, et al. (1993) Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. The American journal of tropical medicine and hygiene 48: 324-331.
64. Kurane I, Innis B, Nimmannitya S, Nisalak A, Meager A, et al. (1991) Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. The Journal of clinical investigation 88: 1473-1480.
65. Rathakrishnan A, Wang SM, Hu Y, Khan AM, Ponnampalavanar S, et al. (2012) Cytokine Expression Profile of Dengue Patients at Different Phases of Illness. PloS one 7: e52215.
66. Chakravarti A, Kumaria R (2006) Circulating levels of tumour necrosis factoralpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian Journal of Medical Research 123: 25.
67. Braga E, Moura P, Pinto L, Ignácio S, Oliveira M, et al. (2001) Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Memórias do Instituto Oswaldo Cruz 96: 229-232.
68. Fernández-Mestre M, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z (2004) TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue antigens 64: 469-472.
69. Royall J, Berkow R, Beckman J, Cunningham M, Matalon S, et al. (1989) Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. The American journal of physiology 257: 410.
70. Raghupathy R, Chaturvedi U, Al-Sayer H, Elbishbishi E, Agarwal R, et al. (1998) Elevated levels of IL-8 in dengue hemorrhagic fever. Journal of medical virology 56: 280-285.
71. Juffrie M, van Der Meer G, Hack C, Haasnoot K, Sutaryo, et al. (2000) Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infection and immunity 68: 702-707.
72. Talavera D, Castillo A, Dominguez M, Gutierrez A, Meza I (2004) IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. The Journal of general virology 85: 1801-1813.
73. Chau T, Quyen N, Thuy T, Tuan N, Hoang D, et al. (2008) Dengue in Vietnamese infants-results of infection-enhancement assays correlate with agerelated disease epidemiology, and cellular immune responses correlate with disease severity. The Journal of infectious diseases 198: 516-524.
74. de-Oliveira-Pinto L, Marinho C, Povoa T, de Azeredo E, de Souza L, et al. (2012) Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. PloS one 7.
75. Bigger C, Guerra B, Brasky K, Hubbard G, Beard M, et al. (2004) Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. Journal of virology 78: 13779-13792.
76. Wright H, Alex P, Nguyen T, Bader T, Gurakar A, et al. (2005) Multiplex cytokine profiling of initial therapeutic response in patients with chronic hepatitis C virus infection. Digestive diseases and sciences 50: 1793-1803.
77. Bozza F, Cruz O, Zagne S, Azeredo E, Nogueira R, et al. (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC infectious diseases 8: 86.
78. Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, et al. (2010) Tumor necrosis factor-alpha, transforming growth factor-1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Human immunology 71: 1135-1140.
79. Laur F, Murgue B, Deparis X, Roche C, Cassar O, et al. (1998) Plasma levels of tumour necrosis factor alpha and transforming growth factor beta-1 in children with dengue 2 virus infection in French Polynesia. Transactions of the Royal Society of Tropical Medicine and Hygiene 92: 654-656.
80. Luplertlop N, Missé D (2008) MMP cellular responses to dengue virus infectioninduced vascular leakage. Jpn J Infect Dis 61: 298-301.
81. Nguyen T, Lei H-Y, Nguyen T, Lin Y-S, Huang K-J, et al. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. The Journal of infectious diseases 189: 221-232.
82. Tseng C-S, Lo H-W, Teng H-C, Lo W-C, Ker C-G (2005) Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS immunology and medical microbiology 43: 99-102.